Dogecoin Cash, Inc. (DOGP)
Dogecoin Cash, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Mesquite, NV, US. The stock last traded at $0.01, down 2.16% on the session, giving a market capitalisation of $1.2M. On trailing twelve-month figures it carries a trailing P/E of -1.91, a net margin of -89.3%. Its beta of 2.60 implies it has historically moved more than the broad market.
Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" — a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain — and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.
Dogecoin Cash, Inc. is most often compared with the following Healthcare names: